Sandoz Group AG
SIX:SDZ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sandoz Group AG
SIX:SDZ
|
CH |
Intrinsic Value
The intrinsic value of Sandoz Group AG (SDZ) under the Base Case is 45.14 CHF per share. Compared with the current market price of 76.68 CHF, the stock appears Overvalued by 41% .
The intrinsic value is calculated using the DCF method. The model assumes Sandoz's net margin jumps to 14% in 2026 and reaches 18% by 2031, above any of the last six years. Revenue grows about 5.7% a year over the next five years, versus 2.9% over the last five.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Sandoz Group Does
Sandoz Group AG makes generic medicines and biosimilars, which are lower-cost versions of brand-name drugs and complex biologic medicines after patents expire. It also supplies certain established medicines such as antibiotics and other hospital and retail pharmacy products. The company sells to wholesalers, pharmacies, hospitals, and health systems that need reliable access to medicines at lower prices.
- Headquarters
- Switzerland CH
- Employees
- 22 356
- IPO date
- Oct 4, 2023
Earnings Waterfall
Sandoz Group AG
The intrinsic value for Sandoz Group AG (SDZ) under the Base Case is 45.14 CHF.
Compared with the current market price of 76.68 CHF, the stock appears Overvalued by 41% .